361 related articles for article (PubMed ID: 7815831)
1. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
[TBL] [Abstract][Full Text] [Related]
2. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994 Jun; 8(6):914-7. PubMed ID: 8207983
[TBL] [Abstract][Full Text] [Related]
3. Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells.
Delva L; Cornic M; Balitrand N; Guidez F; Micléa JM; Delmer A; Teillet F; Fenaux P; Castaigne S; Degos L
Blood; 1993 Oct; 82(7):2175-81. PubMed ID: 8400267
[TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
5. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.
Guidez F; Huang W; Tong JH; Dubois C; Balitrand N; Waxman S; Michaux JL; Martiat P; Degos L; Chen Z
Leukemia; 1994 Feb; 8(2):312-7. PubMed ID: 8309256
[TBL] [Abstract][Full Text] [Related]
6. [Biological parameters of the efficiency of retinoic acid in acute leukemia].
Chomienne C; Cornic M; Castaigne S; Lefebvre P; de Thé H; Dejean A; Degos L
C R Seances Soc Biol Fil; 1991; 185(6):456-63. PubMed ID: 1822394
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
8. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
9. Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacy.
Agadir A; Cornic M; Lefebvre P; Gourmel B; Balitrand N; Degos L; Chomienne C
Leukemia; 1995 Jan; 9(1):139-45. PubMed ID: 7845008
[TBL] [Abstract][Full Text] [Related]
10. All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy.
Degos L
Int J Cell Cloning; 1992 Mar; 10(2):63-9. PubMed ID: 1312109
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of acute promyelocytic leukemia by all trans retinoic acid].
Castaigne S; Degos L
C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.
Chomienne C; Balitrand N; Ballerini P; Castaigne S; de Thé H; Degos L
J Clin Invest; 1991 Dec; 88(6):2150-4. PubMed ID: 1661301
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
Dubois C; Schlageter MH; de Gentile A; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y; Degos L
Leukemia; 1994 Oct; 8(10):1750-7. PubMed ID: 7523800
[TBL] [Abstract][Full Text] [Related]
14. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
Robak T
Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
[TBL] [Abstract][Full Text] [Related]
15. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
[TBL] [Abstract][Full Text] [Related]
16. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients.
Cornic M; Delva L; Guidez F; Balitrand N; Degos L; Chomienne C
Cancer Res; 1992 Jun; 52(12):3329-34. PubMed ID: 1317749
[TBL] [Abstract][Full Text] [Related]
17. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
[TBL] [Abstract][Full Text] [Related]
18. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
Tallman MS
Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
[TBL] [Abstract][Full Text] [Related]
19. Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone.
Ohashi H; Ichikawa A; Takagi N; Hotta T; Naoe T; Ohno R; Saito H
Leukemia; 1992 Aug; 6(8):859-62. PubMed ID: 1353552
[TBL] [Abstract][Full Text] [Related]
20. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
Tallman MS
Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]